Patients with generalized pustular psoriasis (GPP) experience frequent flares, and treatment alterations of off-label agents are frequently observed.

Biologics targeting interleukin (IL)-12, IL-23, and IL-17 may have valuable safety benefits among older adults with psoriatic disease, as a lower rate of serious infection was observed among these ...

Like other types of psoriasis, GPP is considered autoimmune. These conditions are not infectious diseases and cannot spread to others upon contact. There’s currently no cure for GPP, and due to ...

Icotrokinra appears to be an effective treatment for adolescents with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study.

Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...

Fast Five Quiz: Plaque Psoriasis Management How much do you know about the management of plaque psoriasis? Test your knowledge with this quick quiz. Medscape, April 09, 2025 Study Links Obesity to ...

A group of researchers have created four novel laboratory-developed tests that can distinguish between and subclassify atopic dermatitis and psoriasis in a skin biopsy, according to a press release.

In people with psoriasis, systemic inflammation may have an indirect but significant influence on the relationship between cardiovascular disease (CVD) risk and skin disease severity. A recent ...

Please provide your email address to receive an email when new articles are posted on . Overall, 84.1% and 70.5% of patients treated with icotrokinra achieved IGA 0 or 1 and PASI 90, respectively ...

1998; Helwig, 2000; Stein, 2000). Psoriasis affects 2% of the U.S. population, accounting for 10% of outpatient visits to dermatologists (Thompson, Feldman, & Fleischer, 1998). In a university ...